Research graph
References from Real‐World Claims Data on Prescribed Drugs and the Associated Drug–Drug Interaction Risk in Sickle Cell Disease in the United States. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/ajh.24235
10.1002/ajh.24235 · External reference
10.1080/14656566.2024.2317336
10.1080/14656566.2024.2317336 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
2024 · External reference
10.1002/cpt.2931
10.1002/cpt.2931 · External reference
10.1111/cts.13785
10.1111/cts.13785 · External reference
10.1002/cpt.2988
10.1002/cpt.2988 · External reference
10.1002/cpt.2236
10.1002/cpt.2236 · External reference
10.1208/s12248-023-00832-3
10.1208/s12248-023-00832-3 · External reference
10.1002/cpt.3652
10.1002/cpt.3652 · External reference
10.1371/journal.pone.0313289
10.1371/journal.pone.0313289 · External reference
Unresolved reference
External reference
10.1111/cts.13741
10.1111/cts.13741 · External reference
10.1007/s00228-017-2215-5
10.1007/s00228-017-2215-5 · External reference
10.1007/s00228-006-0120-4
10.1007/s00228-006-0120-4 · External reference
10.1016/j.clpt.2004.08.018
10.1016/j.clpt.2004.08.018 · External reference
10.1007/s00228-022-03278-2
10.1007/s00228-022-03278-2 · External reference
10.1007/s00228-020-02981-2
10.1007/s00228-020-02981-2 · External reference
10.2196/42816
10.2196/42816 · External reference
10.1016/s2352-3026(24)00384-3
10.1016/s2352-3026(24)00384-3 · External reference
10.1056/nejmoa1903212
10.1056/nejmoa1903212 · External reference
The Highest‐Cost Medicaid Enrollees With Sickle Cell Disease Had Annual Health Care Expenditures Nearing $200 000
2024 · External reference
10.57264/cer-2025-0006
10.57264/cer-2025-0006 · External reference
10.1001/jama.2015.3075
10.1001/jama.2015.3075 · External reference
10.1080/17474086.2022.2031967
10.1080/17474086.2022.2031967 · External reference
